The 5-lipoxygenase (5-LO) cascade and atherosclerosis in mice and men

被引：0
|
作者：
Loetzer, K [1 ]
Graebner, R [1 ]
Kaiser, B [1 ]
John, N [1 ]
Moos, M [1 ]
Spanbroek, R [1 ]
Hildner, M [1 ]
Funke, H [1 ]
Habenicht, AJR [1 ]
机构：
[1] Univ Jena, Sch Med, Inst Vasc Med, D-07743 Jena, Germany
来源：
CHEMISTRY AND PHYSICS OF LIPIDS | 2004年 / 130卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [21] The role of human 5-Lipoxygenase (5-LO) in carcinogenesis - a question of canonical and non-canonical functions
    Kahnt, Astrid S.
    Haefner, Ann-Kathrin
    Steinhilber, Dieter
    ONCOGENE, 2024, 43 (18) : 1319 - 1327
  • [22] HUMAN ALVEOLAR MACROPHAGES (HAMS) HAVE GREATER AMOUNTS OF 5-LIPOXYGENASE (5-LO) THAN MONOCYTES
    PUERINGER, RJ
    BAHNS, CC
    HUNNINGHAKE, GW
    CLINICAL RESEARCH, 1991, 39 (02): : A386 - A386
  • [23] ROLE OF CORTICOSTERONE IN MODULATION OF EICOSANOID BIOSYNTHESIS AND ANTIINFLAMMATORY ACTIVITY BY 5-LIPOXYGENASE (5-LO) AND CYCLOOXYGENASE (CO) INHIBITORS
    TOMCHEK, LA
    HARTMAN, DA
    LEWIN, AC
    CALHOUN, W
    CHAU, TT
    CARLSON, RP
    AGENTS AND ACTIONS, 1991, 34 (1-2): : 20 - 24
  • [24] Glomerular localization of 5-lipoxygenase and (5-LO) activating protein (FLAP) in a rat model of proliferative glomerulonephritis (GN).
    Uda, S
    Munger, KA
    Badr, KF
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1936 - A1936
  • [25] Arachidonate 5-lipoxygenase (5-LO) promoter genotype and risk of myocardial infarction: A case-control study
    Maznyczka, Annette
    Braund, Peter
    Mangino, Massimo
    Samani, Nilesh J.
    ATHEROSCLEROSIS, 2008, 199 (02) : 328 - 332
  • [26] Inhibition of the delayed rectifier K+ current by 5-lipoxygenase (5-LO) inhibitors in rat pulmonary arterial myocytes
    Smirnov, SV
    Knock, GA
    Aaronson, PI
    JOURNAL OF PHYSIOLOGY-LONDON, 1998, 507P : 72P - 73P
  • [27] LPS PRIME HUMAN NEUTROPHILS FOR THE SYNTHESIS OF 5-LIPOXYGENASE (5-LO) PRODUCTS VIA THE CD14 ANTIGEN - INCREASED 5-LO ACTIVITY AND ARACHIDONIC-ACID (AA) AVAILABILITY
    SURETTE, ME
    GOSSELIN, J
    BORGEAT, P
    FASEB JOURNAL, 1994, 8 (04): : A317 - A317
  • [28] Virtual screening, ADME study, and molecular dynamic simulation of chalcone and flavone derivatives as 5-Lipoxygenase (5-LO) inhibitor
    Mohd Amin, Siti Norhidayah
    Md Idris, Muhd Hanis
    Selvaraj, Manikandan
    Mohd Amin, Siti Norhidayu
    Jamari, Hisyam
    Kek, Teh Lay
    Salleh, Mohd Zaki
    MOLECULAR SIMULATION, 2020, 46 (06) : 487 - 496
  • [29] EFFECT OF A 5-LIPOXYGENASE (5-LO) CYCLOOXYGENASE (CO) INHIBITOR, WY-47,288, ON CUTANEOUS MODELS OF INFLAMMATION
    CARLSON, RP
    ONEILLDAVIS, L
    CALHOUN, W
    DATKO, L
    MUSSER, JH
    KREFT, AF
    CHANG, JY
    AGENTS AND ACTIONS, 1989, 26 (3-4): : 319 - 328
  • [30] Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice
    Ghazalpour, A
    Wang, XP
    Lusis, AJ
    Mehrabian, M
    GENETICS, 2006, 173 (02) : 943 - 951
12345